PAPER Pilarzyk K, Porcher L, Capell WR, Burbano SD, Davis J, Fisher JL, Gorny N, Petrolle S, Kelly MP

Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.

Aging Cell. 2022 Oct;21(10):e13687. Epub 2022 Sep 8 PubMed: 36073342

PAPER He CY, Wang ZT, Shen YY, Shi AY, Li HY, Chen DW, Zeng GH, Tan CR, Yu JT, Zeng F, Wang YJ, Alzheimer's Disease Neuroimaging Initiative

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid-β deposition in the brain.

CNS Neurosci Ther. 2022 Dec;28(12):2218-2229. Epub 2022 Sep 8 PubMed: 36074475

PAPER Hammers DB, Kostadinova RV, Spencer RJ, Ikanga JN, Unverzagt FW, Risacher SL, Apostolova LG, Alzheimer’s Disease Neuroimaging Initiative

Sensitivity of memory subtests and learning slopes from the ADAS-Cog to distinguish along the continuum of the NIA-AA Research Framework for Alzheimer's Disease.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2022 Sep 8;:1-19. PubMed: 36074015

PAPER Mandal PK, Goel A, Bush AI, Punjabi K, Joon S, Mishra R, Tripathi M, Garg A, Kumar NK, Sharma P, Shukla D, Ayton SJ, Fazlollahi A, Maroon JC, Dwivedi D, Samkaria A, Sandal K, Megha K, Shandilya S

Hippocampal glutathione depletion with enhanced iron level in patients with mild cognitive impairment and Alzheimer's disease compared with healthy elderly participants.

Brain Commun. 2022;4(5):fcac215. Epub 2022 Aug 20 PubMed: 36072647

PAPER Mukerjee N, Das A, Jawarkar RD, Maitra S, Das P, Castrosanto MA, Paul S, Samad A, Zaki ME, Al-Hussain SA, Masand VH, Hasan MM, Bukhari SN, Perveen A, Alghamdi BS, Alexiou A, Kamal MA, Dey A, Malik S, Bakal RL, Abuzenadah AM, Ghosh A, Md Ashraf G

Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer's disease.

Front Aging Neurosci. 2022;14:878276. Epub 2022 Aug 22 PubMed: 36072483

PAPER Parvizi T, König T, Wurm R, Silvaieh S, Altmann P, Klotz S, Rommer PS, Furtner J, Regelsberger G, Lehrner J, Traub-Weidinger T, Gelpi E, Stögmann E

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease.

Front Aging Neurosci. 2022;14:887498. Epub 2022 Aug 22 PubMed: 36072480

PAPER Zuroff L, Wisse LE, Glenn T, Xie SX, Nasrallah IM, Habes M, Dubroff J, de Flores R, Xie L, Yushkevich P, Doshi J, Davatsikos C, Shaw LM, Tropea TF, Chen-Plotkin AS, Wolk DA, Das S, Mechanic-Hamilton D

Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline.

J Alzheimers Dis Rep. 2022;6(1):411-430. Epub 2022 Jul 22 PubMed: 36072364

PAPER Duan K, Ma Y, Tan J, Miao Y, Zhang Q

Identification of genetic molecular markers and immune infiltration characteristics of Alzheimer's disease through weighted gene co-expression network analysis.

Front Neurol. 2022;13:947781. Epub 2022 Aug 22 PubMed: 36071897

PAPER He Y, Cong L, He Q, Feng N, Wu Y

Development and validation of immune-based biomarkers and deep learning models for Alzheimer's disease.

Front Genet. 2022;13:968598. Epub 2022 Aug 22 PubMed: 36072674

PAPER Kakimoto A, Ogura H, Suenaga M, Mishima T, Fujioka S, Ouma S, Matsunaga Y, Tsuboi Y

Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders.

Clin Park Relat Disord. 2022;7:100162. Epub 2022 Aug 27 PubMed: 36072127

PAPER López-Cáceres A, Cruz-Sanabria F, Mayorga P, Sanchez AI, Gonzalez-Nieves S, Ayala-Ramírez P, Zarante I, Matallana D

Association between risk polymorphisms for neurodegenerative diseases and cognition in colombian patients with frontotemporal dementia.

Front Neurol. 2022;13:675301. Epub 2022 Aug 22 PubMed: 36071893

PAPER Yoshimatsu S, Seki F, Okahara J, Watanabe H, Sasaguri H, Haga Y, Hata JI, Sanosaka T, Inoue T, Mineshige T, Lee CY, Shinohara H, Kurotaki Y, Komaki Y, Kishi N, Murayama AY, Nagai Y, Minamimoto T, Yamamoto M, Nakajima M, Zhou Z, Nemoto A, Sato T, Ikeuchi T, Sahara N, Morimoto S, Shiozawa S, Saido TC, Sasaki E, Okano H

Multimodal analyses of a non-human primate model harboring mutant amyloid precursor protein transgenes driven by the human EF1α promoter.

Neurosci Res. 2022 Dec;185:49-61. Epub 2022 Sep 6 PubMed: 36075457

PAPER Avey JP, Schaefer KR, Noonan CJ, Muller CJ, Mosley M, Galvin JE

Patterns of Healthcare Use and Mortality After Alzheimer's Disease or Related Dementia Diagnosis Among Alaska Native Patients: Results of a Cluster Analysis in a Tribal Healthcare Setting.

J Alzheimers Dis Rep. 2022;6(1):401-410. Epub 2022 Jul 11 PubMed: 36072365

PAPER Soutar MP, Melandri D, O'Callaghan B, Annuario E, Monaghan AE, Welsh NJ, D'Sa K, Guelfi S, Zhang D, Pittman A, Trabzuni D, Verboven AH, Pan KS, Kia DA, Bictash M, Gandhi S, Houlden H, Cookson MR, Kasri NN, Wood NW, Singleton AB, Hardy J, Whiting PJ, Blauwendraat C, Whitworth AJ, Manzoni C, Ryten M, Lewis PA, Plun-Favreau H

Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci.

Brain. 2022 Dec 19;145(12):4349-4367. PubMed: 36074904

PAPER Muronaga M, Terao T, Kohno K, Hirakawa H, Izumi T, Etoh M

Lithium in drinking water and Alzheimer's dementia: Epidemiological Findings from National Data Base of Japan.

Bipolar Disord. 2022 Dec;24(8):788-794. Epub 2022 Sep 13 PubMed: 36073313